Campaign for a
National Drug Plan



Canada's Drug Problem

DRUG INDEX




Direct-to-Consumer
Drug Advertising







Nancy Olivieri receives
the Vanessa Young
Award for Public Guardians












Big Pharma Archive


Canadians Can’t Afford Not to
Have a Public Drug Plan


Click here / Cliquez ici







Campaign for a
National Drug Plan




Campagne pour un
régime national
d’assurance-médicaments




National Pharmaceutical Strategy
Canadian Health Coalition



Firms tied to some MDs who set policy: Treatment advice focuses on drugs, researchers find
Boston Globe, April 2009



CANADIAN RX ATLAS



Canadian governments, employers, unions, and patients currently spend more money on
prescription drugs (about $20 billion in 2007) than is spent on all services provided by physicians
in Canada. At the same time, prescription drug spending per capita varies by over 50% across provinces.
Surprisingly little information is systematically collected to determine which drugs account for most
of the spending in Canada, what factors drive interprovincial variations in spending, and whether
population age is an important cause of spending variations across provinces and trends over time. The
2nd edition of The Canadian Rx Atlas significantly enhances our understanding of medicine use by
providing the first-ever portrait of age-specific patterns of prescription drug use and costs across
provinces. It breaks down nearly $20 billion in prescription drug spending (private and public) and
provides a comprehensive portrait of the factors that drive trends over time and variations across provinces.


CLICK HERE TO DOWNLOAD THE NEW ATLAS

KEY FINDINGS



Québec's 2-tier system a massive subsidy to big pharma
Montreal Gazette, August 2008

Can you afford drugs that may save your life?  Toronto Star / June 10, 2008
Tranquillisers putting children's lives at risk  UK Guardian / April 7, 2008
Big Profits from Drugging Seniors  Common Ground, April 2008
Drug recalls linked to U.S. testing deadlines  Globe and Mail, March 27, 2008
End drug sponsorship of doctors' seminars, medical journal says  Ottawa Citizen, March 25, 2008
Lavish perks from drug companies compromise doctors' ethics  Globe and Mail, March 25, 2008




Publish or Perish
READ THE EDITORIAL
(Ottawa Citizen, January 30, 2008)



Ghost Management:
How Much of the Medical Literature Is Shaped Behind the Scenes
by the Pharmaceutical Industry?

CLICK HERE TO DOWNOLAD
(PLoS, September 2007)




HPV Vaccine Controversy



CLICK HERE TO ENTER



Government by the Pharma, for the Pharma  Suburban, Aug. 2007
Pharma Behaving Badly  Financial Times, August 2007
Bulk buying of drugs would save billions: New Zealand negotiates up to 90% savings  Vancouver Sun, Aug. 2007
Government by the Pharma, for the Pharma  Suburban, Aug. 2007
Prescription for a drug disaster  Common Ground, Aufust 2007
Progressive drug licensing: An opportunity to achieve transparency and accountability?  James Wright, June 2007
Patent nonsense: Evidence tells of an industry out of social control  CMA, August 2006








Clement's Conflict of Interest

Federal Health Minister Tony Clement
owns 25% stake in drug company
(June 2006)

Health Coalition calls on Minister to divest or resign

UPDATE: Clement transfers shares in drug company (October 2006)




Interview with Barbara Mintzes on
Direct to Consumer Drug Advertising and
the CanWest Mediaworks Charter Challenge


CBC Radio's Sunday Morning with Michael Enright
(Audio, Duration: 24 Minutes, January 21, 2007)

Description: CanWest Mediaworks has launched a charter challenge
against Health Canada in order to be allowed to sell advertising to Drug
Companies, similar to the situation in the United States. Barbara Mintzes,
University of British Columbia's Centre for Health Services and Policy
Research, is stunned by the decision and has written and researched
extensively the effect of such advertisements on viewers attitudes to
health and wellness. She spoke with Michael from Paris, France.

Click here to listen to the interview




More information on Direct to Consumer Drug Advertising







Information on the CanWest Mediaworks Charter Challenge




CBS Exposé on Big Pharma Lobbying  CBS, April 2007
New Zealand Court Fines Glaxo for Misleading Advertising  Reuters, March 2007
Taking Back the FDA  New York Times, February 2007
Broken Rx&D Promises: Drug firms' research spending falls short  Canwest News, June 2006
Increasing Drug Costs: Are we getting good value?  July 2006
Financial Ties to Industry Cloud Major Depression Study  Wall Street Journal, June 2006
Patients living in deprived areas were 21% more likely to be precribed sedatives  Sunday Times, July 2006
Drug errors injure more than 1.5 million Americans  Boston Globe, June 2006
Risks and benefits of the profit motive
in the pharmaceutical industry
  Agora, 2006
Drug firms a danger to health: new report  Guardian, June 26, 2006




Don't Swallow Rx&D's Poison Pill
Canadian Health Coalition presentation on Ontario's Bill 102



Pill Pushers: How the drug industry abandoned science for salesmanship  Forbes Magazine, May 2006
Pharmaceutical advertisements often false, misleading: report  NJPIRG Law and Policy Centre, May 2006
Marching to Different Drummers: Health Advocacy Groups in
Canada and Funding from the Pharmaceutical Industry
  Women and Health Protection, Jan. 2005
Pharmaceuticals for healthy people: U.S. selling to the worried well  Le Monde Diplomatique, March 2006
The Real Story Behind Big Pharma's R&D Spending in Canada  BMJ, Sept. 2, 2005
The Real Story Behind Big Pharma's R&D Spending in Canada  CGPA, 2005
CHSPR Health Policy Conference: Towards a National Pharmaceutical Strategy  2006



Vanessa's Story



CLICK HERE TO ENTER



Vioxx ads topped $500M ...This is patient education?  Today's Senior's Network, 2005
Why Most Published Research Findings Are False  PLoS, August 2005
VIOXX disaster exposes the dark downside of corporate rule  May 2005
Health Minister attacks makers of VIOXX  Globe and Mail, Feb. 25, 2006
CBC Radio Documentary: Prescribed to Death  CBC, 2005
VIOXX and Drug Safety Meltdown  U.S. Senate Testimony of David J. Graham, Nov. 2004
Health Canada fails miserably at protecting the public from unsafe drugs  Jan. 4, 2005
UK to publish adverse drug reaction data  Jan. 17, 2005
No more delay: Health Canada must stand on guard for us!  Dec. 23, 2004
Health Canada wins 4th Annual "Code of Silence Award"  May 9, 2004
Big Pharma: Paving The Streets of Hell in Gold  Gary W. Lawson, PhD, DPA, 2005



BOOK REVIEWS:
THE TRUTH ABOUT DRUG COMPANIES


Is there a pill for greed?  Globe and Mail Book Review  Sept. 11, 2004
The truth about drug companies  New York Times Book Review  July 15, 2004


Overdo$ed America: The Broken Promise of American Medicine
British Medical Journal Book Review  Sept. 25, 2004



International Committee of Medical Journal Editors Statement on Clinical Drug Trial Registration  2004
CBC special: How Canada tracks dangerous drugs  CBC, February 2004
CBC database on Adverse Drug Reactions  CBC, February 2004
Health Canada data bank for drug reactions flawed  CBC, February 2004
Your Doctor's Drug Problem  New York Times, Nov. 2003
Scientists want scientific papers freely available  USA Today / August 2004
Which Trend is Unsustainable? Français  CHC, 2004





Making a Killing:            
          The Great Health Grab
New Internationalist, Nov. 2003 (Issue #362)



Report Exonerates Dr. Nancy Olivieri  CMAJ, Nov. 10, 2001
Exposé: High Anxiety  Globe and Mail, Sept. 2003
Whither Seniors' Pharmacare: Lessons from (and for) Canada  Health Affairs, Vol.2, No.3, 2003
High Drug Costs Not Due to Patent Laws: Health Minister  Ottawa Citizen, Feb. 2003
Papers Indicate Bayer Knew of Dangers of Cholesterol Drug Baycol  New York Times, Feb. 2003
Romanow Report: A Stab at Drug Reform  Toronto Star, January 2003
Prescription drugs: Necessary health component or added frill?  CHC Medicare Lobby, Dec. 2002
Pfizer Fined $49 Million For Defrauding Medicaid  Globe and Mail, Oct. 2002
Drug Firms Compromise Research: Ethicist Says (Abstract)  September 2002
Drug Firms Accused of Hurting Health Care  Ottawa Citizen, Sept. 2002
Profiting from Pain: Where Prescription Drug Dollars Go  Families USA, July 2002
Drug Companies Send Doctors on Exotic Vacations  CTV News, May 2002
America's other drug problem  Public Citizen, 2002
Patent laws must be scrapped  Green Shield, May 2002
Doctor's Accept Money To Listen to Drug Dealers  BMJ, May 2002
Drug Companies Maintain "Astounding" Profits  BMJ, May 2002
Drug Ads Can Persuade People They're Sick, Research Shows  Barbara Mintz, May 2002
Too much medicine?  BMJ, April 2002
Drug Scandal: Scientists take cash for scientific papers ghostwritten by drug companies  Feb. 2002
Just How Tainted Has Medicine Become?  Lancet, April 2002
Influence of Direct to Consumer Drug Advertising  Primary Care, February 2002
A National Pharmacare Plan: Combining Efficiency and Equity  Dr. Joel Lexchin, March 2002
Dancing with the porcupine: Rules for governing the University-Industry relationship  CMAJ, Sept. 2001
Off the Charts: Pay, Profits and Spending by Drug Companies  Families USA, July 2001
CHC presentations on legislation to extend drug patent monopolies (Bill S-17)  May 2001
Prescription for Profit: Big Pharma's hold on our healthsystem  Washington Post, June 2001
Big Pharma: Mergers, Drug Costs and Health Care Provider Staffing Ratios  IHSEP, May 2001
The Nursing Shortage and The Drug Connection  Revolution, May 2001
Is Academic Medicine for Sale?  NEJM, May 2000
A Prescription For Plunder: The Multinational Drug Monopoly   CHC, 1998
On Feeding Sharks: Patent Protection, Compulsory Licensing & Int'l Trade Law   March 1997
Need Not Greed: CHC Brief to Parliament on C-91   March 1997